
Ivaford 7.5mg Tablet
Marketer
Leeford Healthcare Ltd
Salt Composition
Ivabradine (7.5mg)
Overview Ivaford 7.5mg Tablet
Cardinol 7.5mg tablets manage angina pectoris (chest pain stemming from heart issues) and persistent congestive heart failure. It enhances cardiac efficiency by reducing heart rate, thus mitigating chest discomfort and lowering the risk of hospital readmission for heart failure. Dosage is tailored to the specific condition. As treatment is typically ongoing, discontinuation requires physician consultation. Consistent daily ingestion with food is recommended. Overdosage may cause bradycardia (slow heart rate), fatigue, and shortness of breath; seek immediate medical advice if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic alterations. Serious adverse effects like syncope (fainting) and significant cardiac rhythm changes necessitate immediate medical attention. Refrain from driving until the drug's impact is understood. Cardinol 7.5mg is contraindicated in patients with severe hepatic impairment, bradycardia, cardiac arrhythmias, hypotension, or recently exacerbated heart failure. Interactions exist with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts at conception, or breastfeeding.
Primary Ingredients of Ivaford 7.5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Ivaford 7.5mg Tablet
Managing angina pectoris and heart failure.
Major Benefits of Ivaford 7.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Ivaford 7.5mg Tablet should be administered with a meal.
Common Side effects of Ivaford 7.5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivaford 7.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 7.5mg Ivaford tablet whole; avoid chewing, crushing, or breaking it. It should be taken with food.
How Ivaford 7.5mg Tablet works:
Cardio-regulating tablets, Ivaford 7.5mg, decrease cardiac rhythm. This mechanism reduces myocardial oxygen demand, thereby enhancing cardiac efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ivaford 7.5mg Tablet may be unsafe; seek medical advice before combining them.
PregnancyUNSAFE
Pregnant individuals should absolutely avoid Ivaford 7.5mg Tablets. Research in both animals and pregnant women reveals substantial risks to the fetus, necessitating consultation with a physician before use.
Breast feedingUNSAFE
Lactation and the use of 7.5mg Ivaford tablets are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Ivaford 7.5mg Tablets, which can induce side effects. These side effects may include transient visual disturbances, primarily phosphenes. Night driving, in particular, should consider the potential for such light flashes.
KidneyCAUTION
Patients with severe kidney impairment should use Ivaford 7.5mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised due to limited data on Ivaford 7.5mg tablet use in this patient population.
LiverCAUTION
Patients with liver impairment should use Ivaford 7.5mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Ivaford 7.5mg tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Ivaford 7.5mg Tablet :
Omit any missed dose of Ivaford 7.5mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ivaford 7.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Behavioral Class | Sinoatrial node I<sub>f</sub> sodium channel blockers |
